Nirusha Arnold,* Mark McLean,† David R Chipps,† N Wah Cheung†
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Hussein Z, Wentworth JM, Nankervis AJ, et al. Effectiveness and side effects of thiazolidinedion for type 2 diabetes: real-life experience from a tertiary hospital. Med J Aust 2004; 181: 536-539. <eMJA full text>
- 2. Graham DJ, Green L, Senior JR, Nourjah P. Troglitazone-induced liver failure: a case study. Am J Med 2003; 144: 299-306.
- 3. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with PPAR-γ ligand rosiglitazone. Hepatology 2003; 38: 1008-1017.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
We acknowledge the contribution of Dr Rob Coles, who supplied much of the data for our study.